News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Sub: Analyst / Investor call
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that an analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended 31st March 2019 is scheduled on 29th May 2019 at 8:30 AM.
Please find attached the dial-in details of the call.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.